Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. November 2019 07:30 ET | Quelle: Metacrine, Inc.

Metacrine to Present at Jefferies 2019 London Healthcare Conference

SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
18. September 2019 07:30 ET | Quelle: Metacrine, Inc.

Metacrine Secures $50 Million Growth Capital Facility from K2 HealthVentures

SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
21. Mai 2019 07:30 ET | Quelle: Metacrine, Inc.

Metacrine to Present at Jefferies 2019 Global Healthcare Conference

SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
06. September 2018 07:30 ET | Quelle: Metacrine, Inc.

Metacrine Appoints Hubert Chen, M.D. as Chief Medical Officer and Andrew Guggenhime to the Board of Directors

SAN DIEGO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., a biotechnology company developing therapies to benefit patients with liver and gastrointestinal diseases (GI), today announced the...
22. Mai 2017 08:00 ET | Quelle: Atlantic Healthcare plc

Atlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indication

CAMBRIDGE, U.K., May 22, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...